Showing 41 - 50 of 123
Persistent link: https://www.econbiz.de/10005971435
This comprehensive collection brings together more than 50 contributions from some of the most influential researchers in health economics. It authoritatively covers theoretical and empirical issues in health economics, with a balanced range of material on equity and efficiency in health care...
Persistent link: https://www.econbiz.de/10011173745
The aim of The Elgar Companion to Health Economics is to take an audience of advanced undergraduates, postgraduates and researchers to the frontier of research in health economics, by providing them with short and easily readable introductions to key topics. The volume brings together 50...
Persistent link: https://www.econbiz.de/10011176307
To determine the willingness to pay (WTP) of senior managers in the UK National Health Service (NHS) for services to help manage performance concerns with doctors, dentists and pharmacists.
Persistent link: https://www.econbiz.de/10010577006
Persistent link: https://www.econbiz.de/10005005594
Persistent link: https://www.econbiz.de/10005005598
This study addresses the complexity in modeling contingent valuation surveys with true zeros and non-ignorable missing responses including “don’t knows†and protest responses. An endogenous switching tobit model is specified to simultaneously estimate the parameters of the...
Persistent link: https://www.econbiz.de/10005063706
Discrete choice experiments (DCEs) in health economics have recently used the mixed logit (MXL) model to incorporate preference heterogeneity. These studies typically use a classical approach to estimation or have specified normal distributions for the attributes. Specifying normal distributions...
Persistent link: https://www.econbiz.de/10005023005
This paper outlines recent advances in the methods of cost-benefit analysis (CBA). Economic evaluations in healthcare can be criticised for, amongst other things, the inappropriate use of incremental cost-effectiveness ratios and the reporting of benefits in terms of cost savings, such as...
Persistent link: https://www.econbiz.de/10005590453
The effects of regular and frequent increases in NHS patient charges on patient utilisation and average net ingredient costs of prescription items are analysed using data on NHS prescribed drugs in England for the period 1979-1985. Separate equations are estimated for non-exempt and exempt adult...
Persistent link: https://www.econbiz.de/10005687272